Chicago, IL 的 心臟疾病 臨床試驗
9 項針對 心臟疾病 的研究正在 Chicago(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
ELEVATE-HFpEF Clinical Study
招募中
- The University of Chicago Medical Center, Chicago
Transition to KPL-387 Monotherapy Dosing & Administration Study
招募中2 期
- Investigational Site 013, Chicago
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
招募中
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- Advocate Christ Medical Center, Chicago
- Northwestern University, Chicago
- University of Chicago, Chicago
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
招募中3 期
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- University of Chicago, Chicago
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
招募中
- University of Chicago, Chicago
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
招募中觀察性研究歡迎健康志工
- University of Chicago Medical Center, Chicago
PARTNER 3 Trial - Aortic Valve-in-Valve
招募中
- Northwestern University Hospital, Chicago
- Rush University Medical Center, Chicago
其他城市的 心臟疾病 試驗
- New York City, NY18 項研究
- Boston, MA14 項研究
- Cleveland, OH13 項研究
- Los Angeles, CA12 項研究
- Portland, OR11 項研究
- Philadelphia, PA11 項研究
- Atlanta, GA10 項研究
- Rochester, MN10 項研究
- Dallas, TX10 項研究
- Durham, NC10 項研究
- Washington, DC9 項研究
- Baltimore, MD9 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌58 項研究
- 癌症(所有類型)51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肥胖症41 項研究
- 肺癌41 項研究
- 卵巢癌36 項研究
- 中風34 項研究
- 大腸直腸癌33 項研究
- 心臟衰竭31 項研究
- 過重28 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月5日。各研究自行設定資格標準;由研究團隊決定參與者資格。